Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
235.80    -6.60 (-2.72%)
Bid:
232.00
Ask:
235.80
Spread: 3.80 (1.638%)
Market Cap: £2.31b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

23 Jun 2020 15:15

RNS Number : 8341Q
Serco Group PLC
23 June 2020
 

23 June 2020

Serco Group plc (the 'Company')

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ORDINARY SHARES OF 2p EACH IN THE COMPANY ('Ordinary Shares')

 

On 19 June 2020, Kevin Craven exercised nominal-cost options granted under the 2009 Serco Performance Share Plan and, on the same date, sold the full balance of Ordinary Shares acquired.

 

A summary of the Ordinary Shares acquired and sold is set out below.

 

Name of PDMR

Grant date of award

Vest date of award

Number of Ordinary Shares acquired

Ordinary Shares sold

Kevin Craven, CEO, UK & Europe

6 April 2017

6 April 2020

220,000

220,000

 

The price for the disposal of the Ordinary Shares was £1.5425 per Share.

 

This announcement is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation 596/2014.

 

The notification of dealing forms for these transactions can be found below.

 

Transaction notification

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Kevin Craven

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO, UK & Europe

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Serco Group plc ('the Company')

b)

 

LEI

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The exercise of nominal-cost options over Ordinary Shares granted on 6 April 2017 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.02

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£4,400

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 2 pence each ('Ordinary Shares')

 

Identification code

ISIN: GB0007973794

b)

 

Nature of the transaction

 

 

The sale of Ordinary Shares following the exercise of nominal-cost options over Ordinary Shares on 19 June 2020 under the Company's 2009 Performance Share Plan.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£1.5425

220,000

d)

 

Aggregated information

- Aggregated volume

220,000

- Price

£339,350

e)

 

Date of the transaction

 

19 June 2020

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUOASRROUNUAR
Date   Source Headline
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20231:10 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20234:07 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSTransaction in Own Shares
12th Apr 20234:34 pmRNSDirector/PDMR Shareholding
12th Apr 20234:33 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
4th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 202310:34 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20237:00 amRNSTransaction in Own Shares
29th Mar 20231:20 pmRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSTransaction in Own Shares
28th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20237:00 amRNSTransaction in Own Shares
24th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20231:46 pmRNSNotice of AGM - Replacement
20th Mar 20231:00 pmRNSNotice of AGM
20th Mar 20237:00 amRNSTransaction in Own Shares
17th Mar 20237:00 amRNSTransaction in Own Shares
16th Mar 20237:00 amRNSTransaction in Own Shares
15th Mar 20237:00 amRNSTransaction in Own Shares
14th Mar 20237:00 amRNSTransaction in Own Shares
13th Mar 20237:00 amRNSTransaction in Own Shares
10th Mar 20237:00 amRNSTransaction in Own Shares
9th Mar 202311:47 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSTransaction in Own Shares
8th Mar 20237:00 amRNSTransaction in Own Shares
7th Mar 20237:00 amRNSTransaction in Own Shares
6th Mar 20237:00 amRNSTransaction in Own Shares
3rd Mar 20237:00 amRNSTransaction in Own Shares
2nd Mar 20231:00 pmRNSAnnual Financial Report
2nd Mar 20237:00 amRNSTransaction in Own Shares
1st Mar 202310:00 amRNSTotal Voting Rights
28th Feb 202311:30 amRNSSerco share repurchase programme
28th Feb 20237:00 amRNS2022 Full Year Results
27th Feb 202310:00 amRNSHolding(s) in Company
23rd Feb 20237:00 amRNSSerco wins CMS rebid valued at $690m
22nd Feb 20239:13 amRNSFY2022 results revised date; guidance unchanged
3rd Jan 202312:15 pmRNSTotal Voting Rights
3rd Jan 202312:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.